Vincent Serra
Chief Operating Officer bij NEOVACS
Profiel
Founder of Wittycell SAS, Vincent Serra currently is Chief Operations & Scientific Officer at Neovacs SA. Dr. Serra is also Vice President of BioSupport AG.
In his past career he was VP-Research & Development Viral Vaccines Division at Abivax SA and Chief Executive & Scientific Officer at Wittycell SAS (a subsidiary of Abivax SA) and Vice President-European Operations at Anosys, Inc.
He received a doctorate from the University of Grenoble.
Actieve functies van Vincent Serra
Bedrijven | Functie | Begin |
---|---|---|
NEOVACS | Chief Operating Officer | - |
BioSupport AG | Corporate Officer/Principal | - |
Eerdere bekende functies van Vincent Serra
Bedrijven | Functie | Einde |
---|---|---|
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Chief Executive Officer | 01-02-2014 |
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 01-02-2005 |
ABIVAX | Corporate Officer/Principal | - |
Opleiding van Vincent Serra
University of Grenoble | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NEOVACS | Health Technology |
ABIVAX | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
BioSupport AG |